ROC5 Antibody

What is ROC5 antibody and what target does it recognize?

ROC5 antibody targets the Homeobox-leucine zipper protein ROC5, a transcription factor that belongs to the HD-ZIP homeobox family, Class IV subfamily. The protein is primarily localized in the nucleus and functions as a homeodomain transcription factor. Also known by synonyms including GL2-5, GLABRA 2-like homeobox protein 5, and HD-ZIP protein ROC5, this protein has the UniProt accession number Q6EPF0.

What are the recommended storage conditions for ROC5 antibody?

ROC5 antibody is typically supplied in a liquid form with 50% glycerol and 0.01M Phosphate Buffered Saline (PBS) at pH 7.4, with 0.03% Proclin 300 as a preservative. For optimal stability and performance, the antibody should be stored at -20°C and avoid repeated freeze-thaw cycles, similar to best practices established for other research antibodies as shown in studies of antibody performance and stability .

What experimental applications is ROC5 antibody suitable for?

Based on its nature as a nuclear-localized transcription factor antibody, ROC5 antibody can be employed in multiple research applications including Western blotting, immunofluorescence microscopy, chromatin immunoprecipitation (ChIP), and immunohistochemistry. The specific applications must be validated for each experimental system, similar to protocols established for other transcription factor antibodies in plant research .

How should ROC5 antibody specificity be validated?

Validation should include positive and negative controls, testing across different experimental conditions, and cross-validation with complementary methods. Western blot analysis should show a single band at the expected molecular weight, while knockout/knockdown samples should show reduced or absent signal. This approach follows standard antibody validation practices established in research protocols for other specialized antibodies .

What considerations are important when using ROC5 antibody for chromatin immunoprecipitation (ChIP) experiments?

ChIP experiments with ROC5 antibody require careful optimization of:

• Crosslinking conditions (1-2% formaldehyde for 10-15 minutes at room temperature)

• Sonication parameters for optimal chromatin fragmentation (200-500bp fragments)

• Antibody concentration (typically 2-5μg per ChIP reaction)

• Appropriate negative controls (IgG and input controls)

The procedure should be optimized similarly to protocols developed for other transcription factor antibodies, with particular attention to binding specificity validation through qPCR analysis of known target sequences .

How can ROC5 antibody be used to study protein-protein interactions in transcriptional complexes?

ROC5 antibody can be employed in co-immunoprecipitation (Co-IP) experiments to identify protein interaction partners. This approach requires:

• Optimization of cell lysis conditions to preserve protein complexes

• Determining optimal antibody-to-protein ratios

• Selection of appropriate washing conditions to reduce background

• Mass spectrometry analysis of co-precipitated proteins

This methodology parallels approaches used with other transcription factor antibodies in research settings, where maintaining native protein interactions is critical .

What approaches can be used to resolve contradictory results when using ROC5 antibody across different experimental systems?

When facing contradictory results with ROC5 antibody:

• Evaluate antibody lot-to-lot variability through comparative testing

• Assess epitope conservation across species or cultivars being studied

• Implement multiple detection methods (Western blot, immunofluorescence, etc.)

• Conduct statistical analysis of replicate experiments to determine significance of variations

These approaches follow best practices in resolving experimental contradictions as demonstrated in studies of other specialized antibodies .

How can ROC5 antibody performance be optimized for detecting low-abundance transcription factors?

For detecting low-abundance ROC5 protein:

• Implement signal amplification techniques like tyramide signal amplification

• Optimize sample preparation to concentrate the target protein

• Use high-sensitivity detection systems (chemiluminescent substrates with extended exposure)

• Consider protein enrichment through nuclear fraction isolation

These methods parallel approaches used in detecting other low-abundance transcription factors as shown in research protocols for specialized antibodies .

What is the recommended Western blotting protocol for ROC5 antibody?

The optimized Western blotting protocol for ROC5 antibody includes:

• Sample preparation:

  • Nuclear extraction buffer (20mM HEPES pH 7.9, 420mM NaCl, 1.5mM MgCl₂, 0.2mM EDTA, 25% glycerol)

  • Addition of protease inhibitors freshly before use

  • Heat denaturation at 95°C for 5 minutes in Laemmli buffer

• Gel electrophoresis and transfer:

  • 10-12% SDS-PAGE for optimal resolution

  • PVDF membrane (0.45μm) transfer at 100V for 1 hour

• Antibody incubation:

  • Blocking with 5% non-fat milk in TBST for 1 hour

  • Primary antibody dilution 1:1000 in blocking buffer, overnight at 4°C

  • Secondary antibody incubation 1:5000 for 1 hour at room temperature

• Detection and analysis:

  • ECL-based detection with 1-5 minute exposure

  • Quantification using β-actin or histone H3 as loading controls

This protocol incorporates best practices from research protocols for nuclear transcription factor detection .

What controls should be included when using ROC5 antibody in immunohistochemistry?

Essential controls for ROC5 antibody immunohistochemistry include:

• Technical controls:

  • Primary antibody omission control

  • Isotype control (matching IgG at equivalent concentration)

  • Absorption control (pre-incubation with immunizing peptide)

• Biological controls:

  • Positive tissue control (known ROC5-expressing tissue)

  • Negative tissue control (tissue with minimal ROC5 expression)

  • Knockout/knockdown control (if available)

These controls follow established validation practices for immunohistochemistry with specialized antibodies .

How should researchers troubleshoot non-specific binding when using ROC5 antibody?

To address non-specific binding issues:

• Optimization strategies:

  • Increase blocking stringency (5-10% BSA or normal serum)

  • Test different detergents in wash buffers (0.05-0.3% Tween-20)

  • Titrate antibody concentration to find optimal signal-to-noise ratio

  • Increase number and duration of wash steps

• Advanced approaches:

  • Pre-adsorption with cell/tissue lysates lacking ROC5

  • Use of protein A/G pre-clearing step before immunoprecipitation

  • Implementation of more stringent washing conditions (high salt buffers)

These troubleshooting approaches parallel methods used for enhancing specificity with other specialized antibodies in research settings .

What statistical approaches are recommended for analyzing ROC5 expression data from antibody-based experiments?

For robust statistical analysis of ROC5 expression data:

• Use a minimum of three biological replicates for each experimental condition

• Apply appropriate normalization to loading controls or reference proteins

• Test data for normality before selecting parametric or non-parametric tests

• Consider ANOVA with post-hoc tests for comparing multiple conditions

• Report effect sizes along with p-values to indicate biological significance

ROC curve analysis can be useful for determining optimal antibody dilution and cutoff values, as demonstrated in studies with other antibodies where receiver operating characteristic (ROC) analysis provided quantitative measures of assay performance .

How can researchers integrate ROC5 antibody data with other -omics approaches?

ROC5 antibody data can be integrated with:

• Transcriptomics:

  • Correlation of protein levels (antibody detection) with mRNA expression

  • Validation of transcription factor binding sites identified in RNA-seq studies

• Epigenomics:

  • Combining ChIP-seq data (using ROC5 antibody) with DNA methylation profiles

  • Integration with histone modification patterns at target loci

• Proteomics:

  • Correlation of ROC5 protein levels with interacting partners

  • Validation of mass spectrometry-identified interaction networks

This multi-omics integration approach follows best practices established for transcription factor studies, enhancing the biological significance of antibody-based findings .

What are best practices for quantifying signal intensity in ROC5 antibody-based detection methods?

For accurate quantification:

• Image acquisition:

  • Ensure signal is within linear dynamic range of detection method

  • Use consistent exposure settings across all samples

  • Include a standard curve when possible

• Analysis:

  • Use appropriate software (ImageJ, etc.) with consistent quantification parameters

  • Subtract local background for each measurement

  • Normalize to appropriate loading controls

  • Apply statistical tests appropriate for data distribution

How can ROC5 antibody be used to study post-translational modifications of the transcription factor?

To study ROC5 post-translational modifications:

• Use phospho-specific or other modification-specific antibodies in conjunction with total ROC5 antibody

• Implement 2D gel electrophoresis to separate modified protein forms before antibody detection

• Perform immunoprecipitation with ROC5 antibody followed by mass spectrometry analysis

• Use lambda phosphatase treatment as a control for phosphorylation studies

These approaches follow methodologies established for studying post-translational modifications of other transcription factors .

What considerations are important when using ROC5 antibody across different plant species?

When extending ROC5 antibody use to different plant species:

• Perform sequence alignment analysis to assess epitope conservation

• Test antibody specificity in each new species with appropriate controls

• Optimize antibody concentration and incubation conditions for each species

• Validate results with complementary approaches (e.g., mass spectrometry)

These cross-species validation steps are essential for ensuring reliable antibody performance across different genetic backgrounds, similar to approaches used with other plant-specific antibodies .